Aaron E Miller Selected Research

Gadolinium

11/2012

Pre-specified subgroup analyses of a placebo-controlled phase III trial (TEMSO) of oral teriflunomide in relapsing multiple sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Aaron E Miller Research Topics

Disease

25	Multiple Sclerosis 10/2022 - 03/2002
9	Relapsing-Remitting Multiple Sclerosis 12/2019 - 03/2014
3	Infections 05/2021 - 03/2014
3	Headache (Headaches) 01/2016 - 03/2014
3	Disease Progression 07/2014 - 03/2002
2	Fatigue 05/2016 - 05/2014
2	Nausea 01/2016 - 10/2015
2	Diarrhea 01/2016 - 10/2015
1	Atrophy 10/2021
1	Lymphopenia (Lymphocytopenia) 01/2020
1	Alopecia (Baldness) 10/2015
1	Hypertension (High Blood Pressure) 10/2015
1	Neutropenia 10/2015
1	Paresthesia (Dysesthesia) 10/2015
1	Arthralgia (Joint Pain) 10/2015
1	Respiratory Tract Infections (Respiratory Tract Infection) 10/2014
1	Mitochondrial Diseases (Mitochondrial Disease) 08/2014

Drug/Important Bio-Agent (IBA)

20	teriflunomideIBA 10/2022 - 11/2012
4	Immunologic Factors (Immunomodulators)IBA 01/2018 - 09/2014
4	Alanine Transaminase (SGPT)IBA 01/2016 - 03/2014
2	ofatumumab FDA Link 12/2019 - 01/2018
1	Amantadine (Aman)FDA LinkGeneric 01/2022
1	InterferonsIBA 01/2020
1	Oligoclonal BandsIBA 01/2018
1	Monoclonal AntibodiesIBA 01/2018
1	Fingolimod Hydrochloride (FTY720)FDA Link 11/2016
1	Dimethyl FumarateIBA 11/2016
1	CeramidesIBA 08/2014
1	MicellesIBA 08/2014
1	LipidsIBA 08/2014
1	Biomarkers (Surrogate Marker)IBA 07/2014
1	Interferon beta-1a FDA Link 05/2014
1	Pharmaceutical PreparationsIBA 03/2014
1	GadoliniumIBA 11/2012
1	Glatiramer Acetate (Copaxone)FDA Link 02/2005

Therapy/Procedure

12	Therapeutics 10/2021 - 03/2002
1	Contraindications 01/2021
1	Immunotherapy 03/2002